Biocrossroads Archives - Page 9 of 9 - The Central Indiana Corporate Partnership

Increases in workforce, wages, exports and a $79 billion economic impact demonstrates Indiana’s life sciences leadership

Raquel Bahamonde2021-04-05T16:47:43-04:00March 5, 2019|

INDIANAPOLIS, Ind., March 5, 2019 -- Indiana’s life sciences industry celebrated an active 2018 with several notable developments and continued its national prominence with a continuation of strong workforce, wages and company statistics. The economic impact of the state’s life sciences industry – comprised of pharmaceutical, medical device and equipment, agbiosciences, research, testing and medical laboratories and biologistics - continues to grow and is now at $79 billion1 (according to data provided to BioCrossroads by the Indiana Business Research Center [IBRC] at the Indiana University Kelley School of Business). Indiana’s number of life sciences companies increased for a second year to 1,7511 from 1,689 last year and an increase of employees, now totaling 56,3231. The average wages for the life sciences sector was $97,6071 per worker, resulting in a life sciences payroll total of $5.5 billion1 for the state. In addition, [...]

Three prominent Indiana life sciences executives join BioCrossroads Board of Directors

Raquel Bahamonde2021-04-05T16:47:43-04:00January 31, 2019|

INDIANAPOLIS (January 31, 2019) — BioCrossroads today announces three prominent members of Indiana’s life sciences community have joined its board of directors: Aaron Schacht, executive vice president – Innovation, Regulatory & Business Development, Elanco US Inc.; J.J. Spegele, vice president, global business solutions, Covance Central Laboratory Services; and Dr. Ram Yeleti, executive vice president / chief physician executive, Community Health Network. Schacht leads research & development, regulatory affairs and business development for Elanco Animal Health, following a 25-year career at Lilly in R&D, Strategy and External Innovation roles. Schacht is currently the Chair of the Board of Directors for AgriNovus Indiana, a sister organization to BioCrossroads within the Central Indiana Corporate Partnership. Spegele has held executive leadership roles in operations, laboratory services, general management and information technology for clinical research organizations. He also served as vice president of global business transformation [...]

IBJ: Indiana life sciences companies raise record $115 million in venture capital

Raquel Bahamonde2021-01-14T12:07:35-05:00January 22, 2019|

The Indianapolis Business Journal's John Russell is reporting that Indiana life sciences companies raised $115 million in venture capital funding in 2018, a three percent jump from 2017 and 133 percent higher than 2015. “The thing that jumped out at me was the variety,” said Brian Stemme, who tracks venture deals for BioCrossroads (CICP's life sciences initiative), pointing to products under development ranging from cancer drugs to tele-health software. [READ MORE] (Sources: IBJ and BioCrossroads)